272 related articles for article (PubMed ID: 10102818)
1. Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition.
Soengas MS; Alarcón RM; Yoshida H; Giaccia AJ; Hakem R; Mak TW; Lowe SW
Science; 1999 Apr; 284(5411):156-9. PubMed ID: 10102818
[TBL] [Abstract][Full Text] [Related]
2. Caspase-9 and Apaf-1 are expressed and functionally active in human neuroblastoma tumor cell lines with 1p36 LOH and amplified MYCN.
Teitz T; Wei T; Liu D; Valentine V; Valentine M; Grenet J; Lahti JM; Kidd VJ
Oncogene; 2002 Mar; 21(12):1848-58. PubMed ID: 11896617
[TBL] [Abstract][Full Text] [Related]
3. Apaf-1 and caspase-9 do not act as tumor suppressors in myc-induced lymphomagenesis or mouse embryo fibroblast transformation.
Scott CL; Schuler M; Marsden VS; Egle A; Pellegrini M; Nesic D; Gerondakis S; Nutt SL; Green DR; Strasser A
J Cell Biol; 2004 Jan; 164(1):89-96. PubMed ID: 14709542
[TBL] [Abstract][Full Text] [Related]
4. The role of Apaf-1, caspase-9, and bid proteins in etoposide- or paclitaxel-induced mitochondrial events during apoptosis.
Perkins CL; Fang G; Kim CN; Bhalla KN
Cancer Res; 2000 Mar; 60(6):1645-53. PubMed ID: 10749135
[TBL] [Abstract][Full Text] [Related]
5. Co-transduction of Apaf-1 and caspase-9 augments etoposide-induced apoptosis in U-373MG glioma cells.
Shinoura N; Sakurai S; Asai A; Kirino T; Hamada H
Jpn J Cancer Res; 2001 Apr; 92(4):467-74. PubMed ID: 11346470
[TBL] [Abstract][Full Text] [Related]
6. Defective cytochrome c-dependent caspase activation in ovarian cancer cell lines due to diminished or absent apoptotic protease activating factor-1 activity.
Wolf BB; Schuler M; Li W; Eggers-Sedlet B; Lee W; Tailor P; Fitzgerald P; Mills GB; Green DR
J Biol Chem; 2001 Sep; 276(36):34244-51. PubMed ID: 11429402
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis in UV-C light irradiated p53 wild-type, apaf-1 and p53 knockout mouse embryonic fibroblasts: interplay of receptor and mitochondrial pathway.
Tomicic MT; Christmann M; Kaina B
Apoptosis; 2005 Dec; 10(6):1295-304. PubMed ID: 16215690
[TBL] [Abstract][Full Text] [Related]
8. Co-transduction of Apaf-1 and caspase-9 highly enhances p53-mediated apoptosis in gliomas.
Shinoura N; Sakurai S; Shibasaki F; Asai A; Kirino T; Hamada H
Br J Cancer; 2002 Feb; 86(4):587-95. PubMed ID: 11870542
[TBL] [Abstract][Full Text] [Related]
9. Transduction of Apaf-1 or caspase-9 induces apoptosis in A-172 cells that are resistant to p53-mediated apoptosis.
Shinoura N; Sakurai S; Asai A; Kirino T; Hamada H
Biochem Biophys Res Commun; 2000 Jun; 272(3):667-73. PubMed ID: 10860812
[TBL] [Abstract][Full Text] [Related]
10. Over-expression of APAF-1 and caspase-9 augments radiation-induced apoptosis in U-373MG glioma cells.
Shinoura N; Sakurai S; Asai A; Kirino T; Hamada H
Int J Cancer; 2001 Jul; 93(2):252-61. PubMed ID: 11410874
[TBL] [Abstract][Full Text] [Related]
11. p53-defective tumors with a functional apoptosome-mediated pathway: a new therapeutic target.
Mashima T; Oh-hara T; Sato S; Mochizuki M; Sugimoto Y; Yamazaki K; Hamada J; Tada M; Moriuchi T; Ishikawa Y; Kato Y; Tomoda H; Yamori T; Tsuruo T
J Natl Cancer Inst; 2005 May; 97(10):765-77. PubMed ID: 15900046
[TBL] [Abstract][Full Text] [Related]
12. Apoptosome-independent pathway for apoptosis. Biochemical analysis of APAF-1 defects and biological outcomes.
Belmokhtar CA; Hillion J; Dudognon C; Fiorentino S; Flexor M; Lanotte M; Ségal-Bendirdjian E
J Biol Chem; 2003 Aug; 278(32):29571-80. PubMed ID: 12773531
[TBL] [Abstract][Full Text] [Related]
13. Inactivation of the apoptosis effector Apaf-1 in malignant melanoma.
Soengas MS; Capodieci P; Polsky D; Mora J; Esteller M; Opitz-Araya X; McCombie R; Herman JG; Gerald WL; Lazebnik YA; Cordón-Cardó C; Lowe SW
Nature; 2001 Jan; 409(6817):207-11. PubMed ID: 11196646
[TBL] [Abstract][Full Text] [Related]
14. Oncogene-dependent apoptosis is mediated by caspase-9.
Fearnhead HO; Rodriguez J; Govek EE; Guo W; Kobayashi R; Hannon G; Lazebnik YA
Proc Natl Acad Sci U S A; 1998 Nov; 95(23):13664-9. PubMed ID: 9811857
[TBL] [Abstract][Full Text] [Related]
15. Caspases and mitochondria in c-Myc-induced apoptosis: identification of ATM as a new target of caspases.
Hotti A; Järvinen K; Siivola P; Hölttä E
Oncogene; 2000 May; 19(19):2354-62. PubMed ID: 10822387
[TBL] [Abstract][Full Text] [Related]
16. Dissecting p53 tumor suppressor functions in vivo.
Schmitt CA; Fridman JS; Yang M; Baranov E; Hoffman RM; Lowe SW
Cancer Cell; 2002 Apr; 1(3):289-98. PubMed ID: 12086865
[TBL] [Abstract][Full Text] [Related]
17. Mutant p53 melanoma cell lines respond differently to CP-31398-induced apoptosis.
Ho CK; Li G
Br J Dermatol; 2005 Nov; 153(5):900-10. PubMed ID: 16225598
[TBL] [Abstract][Full Text] [Related]
18. Characterization of distinct consecutive phases in non-genotoxic p53-induced apoptosis of Ewing tumor cells and the rate-limiting role of caspase 8.
Kovar H; Jug G; Printz D; Bartl S; Schmid G; Wesierska-Gadek J
Oncogene; 2000 Aug; 19(36):4096-107. PubMed ID: 10962570
[TBL] [Abstract][Full Text] [Related]
19. Apaf-1 and caspase-9 accelerate apoptosis, but do not determine whether factor-deprived or drug-treated cells die.
Ekert PG; Read SH; Silke J; Marsden VS; Kaufmann H; Hawkins CJ; Gerl R; Kumar S; Vaux DL
J Cell Biol; 2004 Jun; 165(6):835-42. PubMed ID: 15210730
[TBL] [Abstract][Full Text] [Related]
20. The p53 stabilizing compound CP-31398 induces apoptosis by activating the intrinsic Bax/mitochondrial/caspase-9 pathway.
Luu Y; Bush J; Cheung KJ; Li G
Exp Cell Res; 2002 Jun; 276(2):214-22. PubMed ID: 12027451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
